Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.0
(2.38%)
CNY 25.0
(2.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.3 Billion CNY | 40.42% |
| 2022 | 929.49 Million CNY | 6.97% |
| 2021 | 868.95 Million CNY | 88466.58% |
| 2020 | 981.13 Thousand CNY | -96.96% |
| 2019 | 32.23 Million CNY | -79.59% |
| 2018 | 157.94 Million CNY | -29.07% |
| 2017 | 222.69 Million CNY | 52.03% |
| 2016 | 146.48 Million CNY | 1274.13% |
| 2015 | 10.66 Million CNY | -61.38% |
| 2014 | 27.6 Million CNY | -46.92% |
| 2013 | 52 Million CNY | 73.33% |
| 2012 | 30 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.09 Billion CNY | 0.68% |
| 2024 Q3 | 1.13 Billion CNY | 3.77% |
| 2024 Q1 | 1.36 Billion CNY | 3.44% |
| 2023 FY | 1.3 Billion CNY | 40.42% |
| 2023 Q4 | 1.3 Billion CNY | 1.12% |
| 2023 Q3 | 1.29 Billion CNY | 3.62% |
| 2023 Q2 | 1.24 Billion CNY | 3.45% |
| 2023 Q1 | 1.2 Billion CNY | 29.54% |
| 2022 FY | 929.49 Million CNY | 6.97% |
| 2022 Q4 | 929.49 Million CNY | 1.49% |
| 2022 Q3 | 915.86 Million CNY | 2.36% |
| 2022 Q2 | 894.7 Million CNY | 1.3% |
| 2022 Q1 | 883.21 Million CNY | 1.64% |
| 2021 Q4 | 868.95 Million CNY | 2.79% |
| 2021 Q2 | 824.79 Million CNY | 56481.79% |
| 2021 FY | 868.95 Million CNY | 88466.58% |
| 2021 Q1 | 1.45 Million CNY | 48.57% |
| 2021 Q3 | 845.36 Million CNY | 2.49% |
| 2020 Q2 | 32.83 Million CNY | 1.95% |
| 2020 Q3 | 32.97 Million CNY | 0.42% |
| 2020 Q1 | 32.21 Million CNY | -0.09% |
| 2020 Q4 | 981.13 Thousand CNY | -97.02% |
| 2020 FY | 981.13 Thousand CNY | -96.96% |
| 2019 Q3 | 127.15 Million CNY | -19.15% |
| 2019 FY | 32.23 Million CNY | -79.59% |
| 2019 Q4 | 32.23 Million CNY | -74.65% |
| 2019 Q2 | 157.28 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 157.94 Million CNY | -29.07% |
| 2018 Q2 | 241.1 Million CNY | 0.0% |
| 2018 Q4 | 157.94 Million CNY | 0.0% |
| 2017 FY | 222.69 Million CNY | 52.03% |
| 2016 FY | 146.48 Million CNY | 1274.13% |
| 2015 Q3 | 4 Million CNY | 0.0% |
| 2015 Q4 | 10.66 Million CNY | 166.5% |
| 2015 FY | 10.66 Million CNY | -61.38% |
| 2014 FY | 27.6 Million CNY | -46.92% |
| 2013 FY | 52 Million CNY | 73.33% |
| 2012 FY | 30 Million CNY | 0.0% |